ПЕРИОПЕРАТИВНОЕ ЛЕЧЕНИЕ И ОСЛОЖНЕНИЯ АДЕНОКАРЦИНОМЫ ПИЩЕВОДА И ПИЩЕВОДНО-ЖЕЛУДОЧНОГО ПЕРЕХОДА
https://doi.org/10.21886/2219-8075-2014-4-5-11
Аннотация
Эзофагэоэктомия остается сложным и тяжелым оперативным вмешательством как для пациента, так и для хирурга. Необходим тщательный отбор пациентов, которым возможно выполнение данного вмешательства. Использование современных оперативных методов и технологий и, в некоторых случаях, последовательность вмешательств, помогают снизить операционную травму. Региональная анестезия, индивидуализированный подход к периоперационному лечению боли, ранняя экстубация, ограничение жидкости, активизация пациента, физиотерапия значительно улучшают лечение. Быстрое распознание и агрессивное диагностическое обследование осложнений в послеоперационном периоде необходимы для предотвращения неконтролируемого прогрессирования патофизиологических каскадов. Кооперация между хирургом, анестезиологом, эндоскопистом, рентгенологом и другими специалистами необходима для снижения периоперационных осложнений и смертности при таком травматичном оперативном вмешательстве.
Об авторах
K. Tobias
Отделение общей, висцеральной и травматической хирургии, Больница Аугустинериннен Нотфалль, Кёльнский университет
Германия
Германия
E. Beckurts
Отделение общей, висцеральной и травматической хирургии, Больница Аугустинериннен Нотфалль, Кёльнский университет
Германия
Германия
Список литературы
1. Esophagectomy - it’s not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. Low DE; Kunz S; Schembre D; Otero H; Malpass T; Hsi A; Song G; Hinke R; Kozarek RA //Journal of gastrointestinal surgery. 2007. V.11 P.1395-402.
2. Two thousand transhiatal esophagectomies: changing trends, lessons learned. MB; Marshall B; Chang AC; Lee J; Pickens A; Lau CL //Annals of surgery. 2007. V.246 (3). P. 363-72.
3. Improvements of the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ando N; Ozawa S; Kitagawa Y. //Annals of Surgery. 2000. V.232. P. 225-232.
4. Factors affecting morbidity, mortality and survival in patients undergoing Ivor Lewis esophagogastrectomy. Karl RC; Schreiber R; Boulware D //Annals of Surgery. 2000. V.231. P. 635-643
5. Analysis of reduced death and complication rates after esophageal resection. Whooley BP; Law S; Murthy SC //Annals of Surgery. 2003.V.233. P.338-44
6. Centralisation of oesophagogastric cancer services: can specialist units deliver? MJ; Gossage JA; Stephens J; Strauss D; Botha AJ; Atkinson S; Mason RC. //Annals of the Royal College of Surgeons of England. 2006. V. 88 (6). P. 566-70
7. Hospital volume and hospital mortality for esophagectomy. van Lanschot JJ; Hulscher JB; Buskens CJ; Tilanus HW; ten Kate FJ; Obertop H. //Cancer. 2001. V. 91 (8). P. 1574-8
8. Outcomes of Esophagectomy According to Surgeon’s Training: General vs. Thoracic. Smith BR; Hinojosa MW; Reavis KM; Nguyen NT. //Journal of gastrointestinal surgery. 2008. V. 12. P.1907-11.
9. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. Steyerberg EW; Neville BA; Koppert LB; Lemmens VE; Tilanus HW; Coebergh JW; Weeks JC; Earle CC. //Journal of clinical oncology. 2006. V. 24 (26). P. 4277-84
10. Preoperative risk analysis--a reliable predictor of postoperative outcome after transthoracic esophagectomy? Schröder W; Bollschweiler E; Kossow C; Hölscher AH. //Langenbeck’s archives of surgery. 2006. V. 391 (5). P. 455-60
11. Postoperative Mortality After Esophagectomy for Cancer: Development of a Preoperative Risk Prediction Model. Jin Ra, E. Carter Paulson, John Kucharczuk, Katrina Armstrong, Christopher Wirtalla, Rachel Rapaport-Kelz, Larry R. Kaiser, Francis R. Spitz, //Annals of Surgical Oncology. 2008. V.16(1). P.228
12. Organ function index: a predictive marker of operative mortality based on multiple organ dysfunctions in patients with esophageal cancer. Saito T; Shimoda K; Kinoshita T; Shigemitsu Y; Miyahara M; Nakamura A; Kobayashi M. //Japanese journal of clinical oncology. 1993. V. 23 (4). P. 238-45
13. The Influence of Technical Complications on Postoperative. Outcome and Survival After Esophagectomy. Lorenzo E. Ferri, MD, FRCS (C), Simon Law, MS, MA (Cantab), MBBChir, FRCS (Edin), FACS, Kam-Ho Wong, MBBS, FRCS (Edin), Ka-Fai Kwok, MBBS, FRCS (Edin), and John Wong, MD, PhD, FRACS, FACS (Hon) //Annals of Surgical Oncology. 2006. V.13(4). P. 557-64
14. Microbiological and clinical effects of selective bowel decontamination in transthoracic resection of carcinoma of the esophagus and cardia //Chirurg. 2001. V. 72. P. 1160-1170
15. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Liberati A.; D’Amico R; Pifferi //Cochrane Database Syst. Review. 2004. CD 000022
16. Immediate extubation and epidural analgesia allow safe management in a high-dependency unit after two-stage oesophagectomy. Results of eight years of experience in a specialized upper gastrointestinal unit in a district general hospital. Chandrashekar MV; Irving M; Wayman J; Raimes SA; Linsley A. //British journal of anaesthesia. 2003. V. 90 (4). P. 474-9
17. Thoracic epidural analgesia or intravenous morphine analgesia after thoracoabdominal esophagectomy: a prospective follow-up of 201 patients. Rudin A; Flisberg P; Johansson J; Walther B; Lundberg CJ. //Journal of cardiothoracic and vascular anesthesia. 2005. V. 19 (3). P.350-7
18. Association of No Epidural Analgesia with Postoperative Morbidity and Mortality after Transthoracic Esophageal Cancer Resection. Cense S; Lagarde K; de Jong J; Omloo O; . Busch C; . Henny J . van Lanschot. //Journal of the American College of Surgeons. 2006. V. 202 (3). P. 395 – 400
19. Thoracic epidural anesthesia improves the gastric microcirculation during experimental gastric tube formation. Lázár G; József K; Szabolcs A; Gábor H; Antal W; Károly S; Paszt A; Balogh A; Mihály B. //Surgery. 2003. V. 134 (5). P. 799 - 805
20. Anaesthesia for oesophagectomy. Pennefather SH. //Current Opinion in Anaesthesiology. 2007. V. 20(1). P. 15-20
21. Fluid management and postoperative respiratory disturbances in patients with transthoracic esophagectomy for carcinoma.Takashi K; Tadanori M; Yoshihiko. //Journal of Clinical Anesthesia. 2002. V. 14. P.252–6
22. A comparative study of the transhiatal laparoscopic approach versus laparoscopic gastric mobilisation and right open transthoracic esophagectomy for esophageal cancer management. Benzoni E; Terrosu G; Bresadola V; Uzzau A; Intini S; Noce L; Cedolini C; Bresadola F; De Anna D. //Journal of gastrointestinal and liver diseases. 2007. V.16(4). P.395-401
23. Hand-assisted laparoscopic construction of gastric conduit for thoracic esophageal cancer. Aoki T; Tsuchida A; Osaka Y; Takagi Y; Shinohara M; Okada R; Tomioka H; Koyanagi Y //Diagnostic and Therapeutic Endoscopy. 2001. V. 7. P. 75-81
24. Does transthoracic compared to transhiatal resection alter the early postoperative course of oesophagectomy? Márton S; Szakmány T; Papp A; Cseke L; Horváth PO. //Diseases of the esophagus. 2005. V. 18 (3). P.155-9
25. Minimally invasive esophagectomy: Outcomes in 222 patients. Luketich JD; Alvel-Rivera M; Buenaventura PO. //Annals of Surgery. 2003. V. 240. P.486-94
26. Results of the combination of open transthoracic esophagectomy with laparoscopic gastric tube formation for esophageal cancer. Cense HA; Busch OR; Bemelman WA; Obertop H; van Lanschot JJ. //Digestive Surgery. 2006. V. 23. P.164-8
27. Postoperative recovery of microcirculation after gastric tube formation. Schröder W; Stippel D; Gutschow C; Leers J; Hölscher AH. //Langenbeck’s archives of surgery. 2004. V. 389 (4). P.267-71
28. Laparoscopic Ishemic Conditioning of the Stomach for Esophageal Replacement. Hoelscher A.H.; Schneider P.M.; Gutschow C.; Schroeder W. //Annals of Surgery. 2007. V. 245 (2). P.241-6
29. Ösophaguscarcinom: Zweizeitiges Operieren als Mediastini-tisprophylaxe beim Risikopatienten. Stein HJ; Bartels H; Siewert JR. //Chirurg. 2001. V. 72. P. 881–6
30. Catastrophic complications of the cervical esophagogastric anastomosis. Iannettoni MD, Whyte RI, Orringer MB. J Thorac //Cardiovasc Surg. 1995. V. 110. P. 1493–501
31. Consequences of the bilateral vagus nerve section at a cervical level. Leon X, Orus C, Lopez M, Sainz S, Quer M. //Acta Otorrinolaringol Esp. 2003. V.54. P.157–60.
32. Vocal cord paralysis after subtotal oesophagectomy. Hulscher JB, van Sandick JW, Devriese PP, et al. //Br J Surg. 1999. V. 86 P.1583–1587.
33. How safe is high intrathoracic esophagogastrostomy? Hoelscher AH; Schroeder W; Bollschweiler E; Beckurts K T, Schneider P M. //Chirurg. 2003. V. 74. P. 726-33
34. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Law S; Wong KH; Kwok KF; Chu KM; Wong J. //Annals of Surgery. 2004. V. 240(5). P.791-800
35. Postoperative Intensive Care Treatment after Esophageal Resection. Stippel D.L.; Beckurts K.T.E. //Chinese-German Journal of Clinical Oncology. 2004. V. 3 (4). P.240-3
36. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. Murthy SC; Law S; Whooley BP. //Journal of Thoracic and Cardiovasc. Surgery. 2003. V. 126. P.1162-67
37. Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. D. L. Stippel, C. Taylan, W. Schröder, K. T. E. Beckurts, A. H. Hölscher. //Diseases of the Esophagus. 2005. V. 18 (4). P.267–273
38. Intravenous Amidarone for acute herat rate control in the critically ill patient with atrial tachyarrythmias. Clemo HF; Wood MA; Gilligan DM. //Am. Journal of Cardiology. 1998.V. 81. P.594-598
39. Amidarone prophylaxis for tachycardias after coronary heart surgery: A randomised, dpoble blind, placebo controlled trial. //Brit. Heart Journal. 1993. V. 70. P.56-60
40. Amidarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Della Karth G; Geppert A; Neunteufl T. //Crit. Are Med. 2001. V. 29. P.1149-53
41. Anastomotic leaks in the upper gastrointestinal tract. J. R. Siewert, H. J. Stein, H. Bartels //Chirurg. 2004. V. 75. P. 1063–1070
42. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Martin LW; Swisher SG; Hofstetter W; Correa AM; Mehran RJ; Rice DC; Vaporciyan AA; Walsh GL; Roth JA. //Annals of surgery. 2005. V. 242 (3). P. 392-9
43. Diagnosis and management of a mediastinal leak following radical oesophagectomy. Griffin SM, Lamb PJ, Dresner SM, Richardson DL, Hayes N. //Br J Surg. 2001. V.88. P.1346–51
44. Symptomatic Malignant Gastroesophageal Anastomotic Leak: Management with Covered. Metallic Esophageal Stents. Shuvro H. Roy-Choudhury Anthony A. Nicholson Kevin R. Wedgwood Richard A. J. Mannion Peter C. Sedman Christopher M. S. Royston David J. Breen. //Am. Journal Radiology. 2001. V. 176. P. 161–5
45. Mortality secondary to esophageal anastomotic leak. Alanezi K; Urschel JD; //Ann Thorac Cardiovasc Surg. 2004. V. 10 (2). P. 71-5
46. Sealing of esophageal perforation or ruptures with expandable metallic stents: A prospective controlled study on treatment efficacy and limitations. E. Johnsson, L. Lundell, B. Liedman. //Diseases of the Esophagus, 2005. V. 18. P.262–6
47. Stent implantation as a treatment option in patients with thoracic anastomotic leaks after esophagectomy. Kauer WKH; Stein HJ; Dittler HJ; Siewert JR; //Surg Endosc. 2008. V. 22. P.50–53
48. Treatment of thoracic esophageal anastomotic leaks and esophageal perforations with endoluminal stents: efficacy and current limitations. Tuebergen D; Rijcken E; Mennigen R; Hopkins AM; Senninger N; Bruewer M; //J Gastrointest Surg. 2008. V. 12. P. 1168–76
49. Treatment of Thoracic Anastomotic Leaks After Esophagectomy With Self-expanding Plastic Stents Michael Hünerbein, Christian Stroszczynski, Kurt T. Moesta, Peter M. Schlag, // Annals of Surgery. 2004, V. 240(5). P. 801-7
50. Pulmonary complications after subtotal oesophagectomy. Nishi M; Hiramatsu Y; Hioki K et al. //Br J Surg. 1988. 75. P.527–30.
51. Postoperative respiratory failure in patients with cancer of esophagus and gastric cardia. Mao YS; Zhang DC; He J; Zhang RG; Cheng GY; Sun KL; Wang LJ; Yang L. //Chinese journal of oncology. 2005. V.27 (12). P. 753-6
52. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Tandon S, Batchelor A, Bullock R, et al. //Br J Anaesth. 2001. V. 86. P.633–638.
53. Oxygen toxicity. Lodato RF; In: Tobin MJ (ed): Principles and Practice of Mechanical Ventilation. New York: McGraw-Hill, 1994. – P.837–56.
54. Timing of extubation after oesopahagectomy. M. T. P. Caldwell, P. G. Murphy, R. Page, T. N. Walsh T. P. J. Henness.// Br. J. Surg. 1993. V. 80. P. 1537-9
55. Feasibility and outcomes of an early extubation policy after esophagectomy. Lanuti M; de Delva PE; Maher A; Wright CD; Gaissert HA; Wain JC; Donahue DM; Mathisen DJ. //The Annals of thoracic surgery. 2006. V.82 (6). P. 2037-41
56. Early extubation vs. late extubation after esophagus resection: a randomized, prospective study Bartels H; Stein HJ; Siewert JR. //Langenbecks Archiv für Chirurgie. 1998. V. 115. P.1074-6
57. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory. Distress Syndrome Network. //N Engl J Med. 2000. V. 342. P.1301–1308.
58. Effect of prone positioning on the survival of patients with acute respiratory failure. Gattinoni L, Tognoni G, Pesenti A, et al. //N Engl J Med. 2001. V.345. P. 568–573.
59. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Nakamura M; Iwahashi M; Nakamori M; Ishida K; Naka T;Iida T; Katsuda M; Tsuji T; Nakatani Y; Yamaue H. //Langenbecks Arch Surg. 2008. V.393. P.127–133
60. Perioperative Granulocyte Colony-Stimulating Factor Does Not Prevent Severe Infections in Patients Undergoing Esophagectomy for Esophageal Cancer. A Randomized Placebo-Controlled Clinical Trial. Schaefer H; Engert A; Grass Guido; Mansmann G; Wassmer G; Hubel K; Loehlein D; Ulrich BC; Lippert, H; Knoefel WT; Hoelscher AH.//Annals of Surgery. 2004. V. 240(1). P.68–75.
Рецензия
Для цитирования:
Tobias K., Beckurts E. ПЕРИОПЕРАТИВНОЕ ЛЕЧЕНИЕ И ОСЛОЖНЕНИЯ АДЕНОКАРЦИНОМЫ ПИЩЕВОДА И ПИЩЕВОДНО-ЖЕЛУДОЧНОГО ПЕРЕХОДА. Медицинский вестник Юга России. 2014;(4):5-11. https://doi.org/10.21886/2219-8075-2014-4-5-11
For citation:
Tobias K., Beckurts E. PERIOPERATIVE AND COMPLICATION MANAGEMENT FOR ADENOCARCINOMA OF THE ESOPHAGUS AND ESOPHAGOGASTRIC JUNCTION. Medical Herald of the South of Russia. 2014;(4):5-11. (In Russ.) https://doi.org/10.21886/2219-8075-2014-4-5-11
Просмотров:
392
Послать статью по эл. почте 